18F‑FDG PET/CT characteristics of pulmonary sclerosing hemangioma vs. pulmonary hamartoma

  • Authors:
    • Lei Jiang
    • Yan Huang
    • Qiying Tang
    • Qingping Zhao
    • Yuan Li
    • Xiaodong Wu
    • Huoqiang Wang
  • View Affiliations

  • Published online on: May 8, 2018     https://doi.org/10.3892/ol.2018.8660
  • Pages: 660-665
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The radiological features of pulmonary sclerosing hemangioma (PSH) and pulmonary hamartoma are poorly specified. Thus, the present study aimed to compare and analyze the characteristics of fluorodeoxyglucose positron emission tomography/computed tomography (18F‑FDG PET/CT) in PSH versus pulmonary hamartoma. 18F‑FDG PET/CT characteristic findings of 12 patients with PSH and 14 patients with pulmonary hamartoma were retrospectively reviewed. A total of 12 lesions were detected from the 12 patients with PSH, of which 3 masses exhibited calcification. The mean diameter and standardized maximum uptake value (SUVmax) were 1.9±0.7 cm and 2.6±1.0, respectively, and there was no significant correlation between the lesion size and SUVmax (P>0.05). For the 14 patients with pulmonary hamartoma, 14 lesions were found, of which 4 exhibited calcification. The mean diameter and SUVmax were 1.7±0.8 cm and 1.5±0.6, respectively, and there was a significant correlation between the size and SUVmax (r=0.625, r2=0.391, P<0.05). Although there was no significant difference between the size of PSH and pulmonary hamartoma (P>0.05), the SUVmax of PSH was significantly higher than that of pulmonary hamartoma (P<0.05). Moreover, the SUVmax of 1.95 was applied as a cutoff for the diagnosis of PSH, and the resulting sensitivity and specificity for PET/CT to differentiate PSH from pulmonary hamartoma were 83.3 and 78.6%, respectively. Although the morphological features were not specific, PSH showed significantly higher FDG accumulation than pulmonary hamartoma on PET/CT imaging, which may aid the differential diagnosis. Further studies with larger populations are warranted to confirm these study results.
View Figures
View References

Related Articles

Journal Cover

July-2018
Volume 16 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Jiang L, Huang Y, Tang Q, Zhao Q, Li Y, Wu X and Wang H: 18F‑FDG PET/CT characteristics of pulmonary sclerosing hemangioma vs. pulmonary hamartoma. Oncol Lett 16: 660-665, 2018.
APA
Jiang, L., Huang, Y., Tang, Q., Zhao, Q., Li, Y., Wu, X., & Wang, H. (2018). 18F‑FDG PET/CT characteristics of pulmonary sclerosing hemangioma vs. pulmonary hamartoma. Oncology Letters, 16, 660-665. https://doi.org/10.3892/ol.2018.8660
MLA
Jiang, L., Huang, Y., Tang, Q., Zhao, Q., Li, Y., Wu, X., Wang, H."18F‑FDG PET/CT characteristics of pulmonary sclerosing hemangioma vs. pulmonary hamartoma". Oncology Letters 16.1 (2018): 660-665.
Chicago
Jiang, L., Huang, Y., Tang, Q., Zhao, Q., Li, Y., Wu, X., Wang, H."18F‑FDG PET/CT characteristics of pulmonary sclerosing hemangioma vs. pulmonary hamartoma". Oncology Letters 16, no. 1 (2018): 660-665. https://doi.org/10.3892/ol.2018.8660